Related Experiment Video
Updated: Feb 10, 2026

Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Biochemical markers of hypertension, prehypertension
L Turgunova1, B Koichubekov1, A Turmuhambetova1
1Karaganda State Medical University, 40, Gogol Street, 100008 Karaganda, Kazakhstan.
Insights
Biochemical markers indicate endothelial dysfunction and target organ damage in prehypertension and hypertension. These markers, including LIGHT and Endocan, are elevated, especially in hypertension.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Clinical Research
Background:
- Hypertension and prehypertension lack sufficient research on biochemical markers for disease mechanisms and target organ damage.
- Endothelial dysfunction and cardiovascular system damage are critical aspects of hypertension and prehypertension.
Purpose of the Study:
- To investigate biochemical markers of endothelial dysfunction and cardiovascular damage in individuals with hypertension and prehypertension.
- To evaluate the levels of specific inflammatory and apoptosis markers in different blood pressure groups.
Main Methods:
- A cross-sectional study involving 938 participants aged 18-65.
- Measurement of blood pressure, glucose, cholesterol, and concentrations of interleukin-6, sFAS, LIGHT, hFABP, NT-ProBNP, and Endocan.
- Classification of participants into normotension, prehypertension, and hypertension groups based on blood pressure levels.
Main Results:
- The prehypertension group showed elevated levels of LIGHT and Endocan compared to the control group.
- The hypertension group exhibited increased levels of LIGHT, Endocan, and heart-type fatty-acid-binding protein (hFABP) compared to the control group.
- These findings suggest a correlation between elevated biochemical markers and the progression of hypertension.
Conclusions:
- The development of prehypertension and hypertension is associated with increased activity of biochemical markers for endothelial dysfunction and target organ damage.
- The observed marker elevations are more pronounced in individuals with established hypertension compared to those with prehypertension.
- These biochemical markers may serve as indicators for early detection and monitoring of cardiovascular risk in hypertensive and prehypertensive individuals.
Objective:
There are insufficient researches aimed at evaluating biochemical markers of mechanisms of formation of AH and lesion of target organs in hypertension and prehypertension. The aim of that research was to study the level of endothelial dysfunction markers and damage to the cardiovascular system in hypertension and prehypertension.
Patients And Methods:
A cross-sectional study was performed among 938 people aged 18 to 65 years. All respondents were surveyed, blood pressure measured, for glucose, cholesterol, interleukin-6, sFAS, LIGHT, hFABP, NT-ProBNP and an Endocan concentrations were tested. Depending on the level of blood pressure participants were splitted into groups with normotension, prehypertension and hypertension.
Results:
Comparing the markers of inflammation, apoptosis and target organ damage in the prehypertensive group, the level of the LIGHT protein was Me=265.2pg/ml (Q25-Q75: 197.7-444.3), in the control group - Me=251.1pg/ml (Q25-Q75: 176.6-376.6), the Endocan level was Me=660.6pg/ml (Q25-Q75: 419.6-867.4) and in the control group Me=587.5pg/ml (Q25-Q75: 401.9-838.1). In the AH group, the level of the LIGHT Me=273.1pg/ml (Q25-Q75: 195.1-455.2), Endocan Me=668.2pg/ml (Q25-Q75: 434.8-977.3), heart-type fatty-acid-binding protein Me=2233.1pg/ml (Q25-Q75: 1518.4-3391.1) exceeded the control group.
Conclusion:
Thus, the development of prehypertension and hypertension is characterized by an increase in the activity of biochemical markers of endothelial dysfunction and damage to target organs, more expressed in the presence of hypertension.
Related Concept Videos
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Hypertension III: Clinical Manifestations and Diagnostic Studies

